The host microbiota is associated with the occurrence and development of esophageal squamous cell carcinoma

Jing Zuo; Yanjun Liu; Wenjing Lv; Yudong Wang; Zhisong Fan; Long Wang; Li Feng; Xue Zhang; Jing Han; Zhiyu Ni

doi:10.1093/procel/pwac024

Protein Cell ›› 2023, Vol. 14 ›› Issue (4) : 294 -298. DOI: 10.1093/procel/pwac024

LETTER

The host microbiota is associated with the occurrence and development of esophageal squamous cell carcinoma

Author information +

History +

PDF (726KB)

Cite this article

Download citation ▾

Jing Zuo, Yanjun Liu, Wenjing Lv, Yudong Wang, Zhisong Fan, Long Wang, Li Feng, Xue Zhang, Jing Han, Zhiyu Ni. The host microbiota is associated with the occurrence and development of esophageal squamous cell carcinoma. Protein Cell, 2023, 14(4): 294-298 DOI:10.1093/procel/pwac024

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011;140:1720–1728.

[2]	Chen X, Winckler B, Lu M, et al. Oral microbiota and risk for esophageal squamous cell carcinoma in a high-risk area of China. PLoS One 2015;10:e0143603.

[3]	Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005;308:1635–1638.

[4]	He Y, Wu W, Wu S, et al. Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis. Microbiome 2018;6:172.

[5]	Li J, Zhao F, Wang Y, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome 2017;5:14.

[6]	Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut 2016;65:330–339.

[7]	Marchesi JR, Dutilh BE, Hall N, et al. Towards the human colorectal cancer microbiome. PLoS One 2011;6:e20447.

[8]	May M, Abrams JA. Emerging insights into the esophageal microbiome. Curr Treat Options Gastroenterol 2018;16:72–85.

[9]	Poore GD, Kopylova E, Zhu Q, et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature 2020;579:567–574.

[10]	Shao D, Vogtmann E, Liu A, et al. Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China. Cancer 2019;125:3993–4002.

[11]	Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin 2021;71:209–249.

[12]	Viaud S, Saccheri F, Mignot G, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013;342:971–976.

[13]	Wang J, Kurilshikov A, Radjabzadeh D, et al. Meta-analysis of human genome-microbiome association studies: the MiBioGen consortium initiative. Microbiome 2018;6:101.

[14]	Yamamura K, Baba Y, Nakagawa S, et al. Human Microbiome fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis. Clin Cancer Res 2016;22:5574–5581.